Sanofi buys US biopharma group Blueprint in $9.1 bln deal-March 2024-www.financetom.com

Sanofi buys US biopharma group Blueprint in $9.1 bln deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sanofi buys US biopharma group Blueprint in $9.1 bln deal

Jun 1, 2025 10:51 PM

PARIS, June 2 (Reuters) - French pharma group Sanofi

has agreed to buy US-based Blueprint Medicines

Corporation ( BPMC ), a biopharmaceutical company specializing

in systemic mastocytosis, a rare immunological disease, the

companies said on Monday.

Under the terms of the acquisition, Sanofi will pay $129.00

per share in cash, representing an equity value of approximately

$9.1 billion.

Previous page： RBC Capital Markets Says Fertilizer Equities Down Week Over Week Next page： Amneal Pharma Gets FDA Approval for New Drug Application of Soman Nerve Agent Pretreatment Pyridostigmine Bromide

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

RBC Capital Markets Says Fertilizer Equities Down Week Over Week

Oct 21, 2024

11:04 AM EDT, 10/21/2024 (MT Newswires) -- RBC Capital Markets 0n Monday said fertilizer equities fell over the past week due to weakness in broader materials, crop prices and oil. RBC said interest in the sector remains somewhat muted ahead of the third-quarter earnings season given soft agriculture conditions and relatively stable but boring fertilizer price dynamics. RBC added that...

Amneal Pharma Gets FDA Approval for New Drug Application of Soman Nerve Agent Pretreatment Pyridostigmine Bromide

Oct 21, 2024

10:41 AM EDT, 10/21/2024 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Monday the US Food and Drug Administration has approved a new drug application for Pyridostigmine Bromide extended-release tablets. The tablets will be used by the US Army and its allies as pretreatment against the effects of soman nerve agent poisoning, the pharmaceutical company said. The once-daily tablets...

Sify Technologies Regains Compliance With Nasdaq Listing Rule

Oct 21, 2024

11:01 AM EDT, 10/21/2024 (MT Newswires) -- Sify Technologies ( SIFY ) said Monday it has regained compliance with the Nasdaq's minimum bid price requirement for continued listing. Sify ( SIFY ) said the closing bid price of its American depositary shares was at least $1 per ADS for 10 consecutive business days from Oct. 4 to Oct. 17, the...

Russian government iPhone purchases rise despite security concerns, Vedomosti reports

Oct 21, 2024

MOSCOW (Reuters) - The Russian government's purchases of iPhones for January through September were four times higher than the same period in 2023, the Vedomosti daily reported on Monday, despite certain officials being banned from using Apple devices. Russia's Federal Security Service (FSB) said in June 2023 that it had uncovered an American espionage operation that compromised thousands of iPhones...